Delivery Order SPE2DR25D1022-SPE2DR26FQS6A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Acamprosate Calcium 333 mg tablets (180-count supply) with a ceiling value of $1,406.00. The award, issued on December 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 19, 2025. This is a non-set-aside competitive award, with performance to be executed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,129.04 to AmerisourceBergen Drug Corp for 180 tablets of Acamprosate Calcium 333 mg, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order was issued on September 13, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,217.28 delivery order is for 180 tablets of acamprosate calcium delayed-release 333 mg, a medication used to treat alcohol dependence. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency (DLA) on October 20, 2025, for the supply of Attruby 356 mg tablets (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,066.68 by the Defense Logistics Agency's Medical Supply Chain on October 14, 2025, with an ultimate completion date of October 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,545.48 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This non-set-aside award represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,920.48 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 4, 2025 and represents a child order under a larger indefinite delivery contract vehicle. The award was not designated as a set-aside contract and reflects the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,020.92 by the Defense Logistics Agency's Medical Supply Chain on September 30, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, is set to be completed by October 1, 2025, with performance taking place at the awardee's Conshohocken facility. The award was made through competitive...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQS6ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,124.80 to supply Acamprosate Calcium 333 mg tablets (180-count) with an ultimate completion date of December 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The IDC serves as a global pharmaceutical support vehicle enabling the company to deliver brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |